Q: Bit confused over 5i responses given on WELL yesterday. 5i initially said results were good and it appeared from answer that there were no negatives. But stock was taking a big hit. Then new questions came in and you responded that there were some negatives (eg decrease in margins, net income and , cash flow). Obviously these are important as sellers stepped in and continue today so far. Usually 5i provide good insight but I think you guys dropped the ball on this one. The initial response should have hi-lited both the good and the bad. And whether the stock had a good run leading up to earnings shouldn't affect your response. Again, I stress usually you give full and fair insight and assessment but not this time.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Is this why the sell off today decrease in the annual numbers comparables?
Adjusted Net Income(1) was $52.4 million, or $0.22 per share in 2023, a decrease of 2% as compared to Adjusted Net Income(1) of $53.7 million, or $0.24 per share in 2022.
Adjusted Free Cashflow was $42.4 million for 2023, a decrease of 13%, as compared to Adjusted Free Cashflow of $48.9 million for 2022. The decrease was mainly due to higher tax and interest payments offsetting the increase in shareholder's EBITDA.
Net Income was $16.6 million or $0.00 per share(2) in 2023, a decrease of 11% as compared to Net Income of $18.7 million or $0.00 per share in 2022.
Adjusted Net Income(1) was $52.4 million, or $0.22 per share in 2023, a decrease of 2% as compared to Adjusted Net Income(1) of $53.7 million, or $0.24 per share in 2022.
Adjusted Free Cashflow was $42.4 million for 2023, a decrease of 13%, as compared to Adjusted Free Cashflow of $48.9 million for 2022. The decrease was mainly due to higher tax and interest payments offsetting the increase in shareholder's EBITDA.
Net Income was $16.6 million or $0.00 per share(2) in 2023, a decrease of 11% as compared to Net Income of $18.7 million or $0.00 per share in 2022.
Q: Hi there, any further insight into WELL after the conference call?
Are they being unduly punished for any particular reasons after good results, and if so, can you explain why the markets are pushing the stock down so hard?
I'm confused as to why this stock keeps being held down with such good growth over the past few years!
Any further help would be greatly appreciated.
Thanks!
Are they being unduly punished for any particular reasons after good results, and if so, can you explain why the markets are pushing the stock down so hard?
I'm confused as to why this stock keeps being held down with such good growth over the past few years!
Any further help would be greatly appreciated.
Thanks!
Q: Here is another take on WELL:
Adjusted gross margin 43.7 % down from 51.3%
Adjusted net income $52.4 million down from
$ 53.7 million
Adjusted free cash flow $42.4 million down from $ 48.9 million.
I am in the camp of Warren Buffet and Charlie Munger who dismiss EBITDA. If you’re going to give a financial number before interest , for instance, you may as well exclude salaries ( or anything else for that matter ) as well.
I own WELL but will keep a closer eye on it. Please shot holes in my thoughts. Thanks. Derek
Adjusted gross margin 43.7 % down from 51.3%
Adjusted net income $52.4 million down from
$ 53.7 million
Adjusted free cash flow $42.4 million down from $ 48.9 million.
I am in the camp of Warren Buffet and Charlie Munger who dismiss EBITDA. If you’re going to give a financial number before interest , for instance, you may as well exclude salaries ( or anything else for that matter ) as well.
I own WELL but will keep a closer eye on it. Please shot holes in my thoughts. Thanks. Derek
Q: Have you crossed paths with this name? Small biopharma company. The Company creates psychedelic-based therapeutics for mental health improvement.
Any thoughts?
Carl
Any thoughts?
Carl
Q: Well is down following earnings report. Your thoughts please.
Q: LMAT does seem to show up on your site. It "manufactures and distributes medical devices for the treatment of peripheral vascular disease". Thoughts on this company growth, competition, etc.? Thanks
- Intuitive Surgical Inc. (ISRG)
- Abbott Laboratories (ABT)
- Edwards Lifesciences Corporation (EW)
- Thermo Fisher Scientific Inc (TMO)
- Zoetis Inc. Class A (ZTS)
- IDEXX Laboratories Inc. (IDXX)
- Globus Medical Inc. Class A (GMED)
- Atrion Corporation (ATRI)
- InMode Ltd. (INMD)
- GE HealthCare Technologies Inc. (GEHC)
Q: Please rank these healthcare stocks in terms of long term growth potential (5-10 years or more): EW, ISRG, IDXX, GEHC, ZTS, ABT, TMO, ATRI, GMED, INMD
Q: Good morning,
Could you please comment on the recent slide in price and whether you would buy at these levels?
Thank you
Could you please comment on the recent slide in price and whether you would buy at these levels?
Thank you
Q: Hi folks,
I am looking to add one more healthcare name to my TFSA. I am thinking of adding either ISRG or LLY. May I have your opinion as to which one you think is best today.
Thanks
I am looking to add one more healthcare name to my TFSA. I am thinking of adding either ISRG or LLY. May I have your opinion as to which one you think is best today.
Thanks
Q: Hi 5i Team - Could you provide an up-to-date assessment on Kneat including its fundamentals, insider ownership, and growth prospects. Thanks.
Q: Would like your review of results. Do you think this is a good entry point for a 5 year hold and what return can I reasonably expect over 5 years, Thanks John
Q: Good morning guys :
Do u agree with Mr donvilles assessment for this this name as potentially being the next great growth stock . Would u buy here at its current price and throw it in a tfsa for many years .
Thx
Mark
Do u agree with Mr donvilles assessment for this this name as potentially being the next great growth stock . Would u buy here at its current price and throw it in a tfsa for many years .
Thx
Mark
- Eli Lilly and Company (LLY)
- UnitedHealth Group Incorporated (DE) (UNH)
- Veeva Systems Inc. Class A (VEEV)
- WELL Health Technologies Corp. (WELL)
Q: Hi Team,
Currently for healthcare exposure I own VEEV and WELL. I was considering replacing VEEV with either LLY or UNH. Would this be advisable? If so, which one would you recommend? Also, regarding Well would you recommend continuing to hold it; or selling it to make a switch for either LLY or UNH as well? What sort of mix here would you recommend? I am looking for long term growth here. Lastly...do you see the healthcare sector in general to be a good place to be right now?
Thanks,
Shane.
Currently for healthcare exposure I own VEEV and WELL. I was considering replacing VEEV with either LLY or UNH. Would this be advisable? If so, which one would you recommend? Also, regarding Well would you recommend continuing to hold it; or selling it to make a switch for either LLY or UNH as well? What sort of mix here would you recommend? I am looking for long term growth here. Lastly...do you see the healthcare sector in general to be a good place to be right now?
Thanks,
Shane.
- Amgen Inc. (AMGN)
- Intuitive Surgical Inc. (ISRG)
- AbbVie Inc. (ABBV)
- Eli Lilly and Company (LLY)
- Profound Medical Corp. (PRN)
Q: Good Morning, Can I please get your opinion on the recent earnings of Viemed and Profound Medical? Are they worth holding for several more quarters, or is it perhaps time to move on. I know you don't have many ideas for Canadian healthcare stocks, other than WELL (which I own), but if you wanted to switch to another CDN or US healthcare stock, what might you consider? Thanks. Brad
Q: Hi Peter,
What are Earnings (total $ amount and $/share estimates) and Revenue $ amount for Well in Q4.
Thank you
What are Earnings (total $ amount and $/share estimates) and Revenue $ amount for Well in Q4.
Thank you
- UnitedHealth Group Incorporated (DE) (UNH)
- Align Technology Inc. (ALGN)
- Arch Capital Group Ltd. (ACGL)
- Interactive Brokers Group Inc. (IBKR)
- Elevance Health Inc. (ELV)
- Fiserv Inc. (FI)
Q: I am currently underweight Health and Financials in the U.S. Can you please provide your top 3-5 picks for each based on current valuations and considering a 5 year+ timeframe??
Q: LLY stock price is struggling lately. Do you have insight to the reasons for the drop? I am interested in a purchase but would like to avoid catching a falling knife. I would appreciate your insight. Thanks you.
- Intuitive Surgical Inc. (ISRG)
- AbbVie Inc. (ABBV)
- Eli Lilly and Company (LLY)
- UnitedHealth Group Incorporated (DE) (UNH)
- iShares Global Healthcare Index ETF (CAD-Hedged) (XHC)
- Novo Nordisk A/S (NVO)
Q: My healthcare sector is very low. I will buying for within my TFSA account and wonder if the ETF XHC would be good ? I can also buy 3 US healthcare companies as I would have enough funds to do so. What would be the best 3 US healthcare companies you would buy if this is preferred over the EFT?
Thanks
Thanks
Q: I have been having a hard time pulling the trigger on Eli Lilly.
It has doubled in the last year.
I know that it is recommended, but it looks potentially overvalued.
Does there long term financials justify the current price?
Should I continue to wait for a pullback, that may never come;)
It has doubled in the last year.
I know that it is recommended, but it looks potentially overvalued.
Does there long term financials justify the current price?
Should I continue to wait for a pullback, that may never come;)